Trial record 1 of 1 for:
a021602
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03375320 |
Recruitment Status :
Active, not recruiting
First Posted : December 18, 2017
Last Update Posted : May 7, 2024
|
Sponsor:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
National Cancer Institute (NCI)
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Actual Primary Completion Date : | August 23, 2023 |
Estimated Study Completion Date : | May 3, 2025 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):